We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Electrical Therapy Device Heals Chronic Wounds

By HospiMedica staff writers
Posted on 01 Apr 2008
A high-tech non-invasive medical device addresses the major problem of healing chronic wounds without interfering with standard conventional therapy. More...


The KFH Novo is a small, portable, medical device that utilizes Bio-Electric Stimulation Therapy (BEST) to deliver extremely low levels of electrical current to wounds. The electrodes are placed at a distance from the wounds, completely outside the normal treatment areas. Parameters are set via an interactive touch-screen panel. BEST has been shown to heal different types of chronic wounds such as venous ulcers, pressure sores, and diabetic ulcers, even where they have been open for longer than a year. The therapy works by enhancing the physiological processes of wound healing, including stimulation of fibroblast cells to activate wound healing; increasing the production of adenosine triphosphate (ATP) to provide the energy needed to restart tissue healing; and increasing the blood and oxygen supply to wound beds by angiogenesis and protein synthesis. BEST also attracts keratinocytes--the major cell type of the epidermis, making up about 90% of epidermal cells--and macrophages by galvanotaxis. The KFH Novo is a product of Kingfisher Healthcare (KFH, Leuven, Belgium).

"The initial results with KFH Novo appear to be very promising. Some wounds that we could not get closed with standard treatments healed completely when KFH Novo was applied,” said Professor Raf Meesen, Ph.D., from Limburg University College (Belgium).

"Chronic wounds remain a major clinical challenge and represents a big burden to health care systems everywhere, both in terms of human and financial resources,” said Dr. Henk Snyman, CEO of KFH. "KFH Novo is a very cost-effective solution, and we expect significant demand from wound care professionals.”


Related Links:
Kingfisher Healthcare
Limburg University College

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.